AKYNZEO (Netupitant and Palonosetron)

**Product type:** Human Prescription Drug

**Active ingredient:** NETUPITANT; PALONOSETRON

**Strength:** 300; .5 mg/1; mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Helsinn Therapeutics (U.S.), Inc.

**Marketing category:** NDA (NDA205718)

**Pharmacologic class:** Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], P-Glycoprotein Inhibitors [MoA], Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC], Substance P/Neurokinin-1 Receptor Antagonist [EPC]